Search for: "SANOFI-PHARMACEUTICALS, INC." Results 121 - 140 of 216
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 May 2009, 7:53 am
Aventis Settles False Claims Act Charges: Aventis Pharmaceutical Inc., a subsidiary of Sanofi-Aventis U.S., has agreed to pay the United States $95.5 million to settle allegations that it violated the False Claims Act by misreporting drug prices to skirt its Medicaid rebate obligations, the department announced Thursday. [read post]
8 Feb 2011, 10:51 pm by Marie Louise
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
21 Nov 2014, 4:00 am by Paula Bremner
Over the past few years the pharmaceutical marketplace has seen an increase in patent “re-litigation” (where a patentee is involved in a second case against another generic). [read post]
5 Mar 2024, 10:55 am by Evangelina Cantu
AbbVie, Inc., et al., Adventist Health System, a 340B covered entity, is suing pharmaceutical manufacturers AbbVie, AstraZeneca, Novartis, Sanofi, and Sandoz alleging that the manufacturers caused violations of the False Claims Act and various state anti-fraud laws when calculating the 340B price for drugs with price increases that outpaced inflation. [read post]
30 Jan 2020, 5:29 am by Brenda Fulmer
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
30 Jan 2020, 5:29 am by Brenda Fulmer
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
10 Aug 2011, 4:30 am by Marie Louise
(Patent Docs) Prezista (Darunavir) – US: Patent infringement complaint filed following a Paragraph IV certification: Tibotec Inc. et al. v. [read post]
2 Dec 2011, 2:00 pm by Bexis
Qualitest Pharmaceuticals Inc., 2011 WL 334671, at *3 (E.D. [read post]
14 Dec 2007, 1:00 am
Gore & Associates Inc. held to have willfully infringed rival C.R. [read post]
31 Dec 2023, 4:29 pm by Thomas James
Copyright Fair Use Andy Warhol Foundation for the Visual Arts, Inc. v. [read post]
11 Apr 2019, 10:59 am by Camilla Hrdy
The compounds of the present invention can be combined with pharmaceutical carriers and administered in a variety of well-known pharmaceutical forms suitable for oral or parental administration to provide compositions useful in the treatment of cardiovascular disorders and particularly mammalian hypertension. (35) (citing Sanofi v Apotex/ramipril). [read post]